Introduction
Materials and methods
Study design and eligibility criteria
Outcome definitions and measurements
Perioperative technique
Statistical analysis
Results
Group I (LVMR) (n = 250) | Group II (PSR) (n = 80) | p value | |
---|---|---|---|
Age (years), mean ± SD | 68 ± 6 | 68 ± 6 | 0.532 |
Sex, n (%) | 0.585 | ||
Male | 54 (21.6%) | 15 (18.8%) | |
Female | 196 (78.4%) | 65 (81.3%) | |
Parity, n (%) | 0.883 | ||
Nulliparous | 14 (7.1%) | 5 (7.7%) | |
Multiparous | 182 (92.9%) | 60 (92.3%) | |
Body mass index, mean ± SD | 30 ± 6 | 30 ± 6 | 0.994 |
Initial symptoms, n (%) | 0.930 | ||
Prolapse only | 87 (34.8%) | 26 (32.5%) | |
Prolapse with incontinence | 111 (44.4%) | 37 (46.3%) | |
Prolapse with OD | 52 (20.8%) | 17 (21.3%) | |
Symptoms duration (months) | < 0.001* | ||
Median (range) | 11 (3–41) | 18 (4–38) | |
Length of prolapse (cm) | 0.223 | ||
Median (range) | 11 (5–31) | 11 (5–32) | |
ASA, n (%) | 0.454 | ||
ASA I | 34 (13.6%) | 7 (8.8%) | |
ASA II | 194 (77.6%) | 64 (80%) | |
ASA III | 22 (8.8%) | 9 (11.3%) | |
Diabetes mellitus, n (%) | 144 (57.6%) | 54 (67.5%) | 0.116 |
Coronary diseases, n (%) | 177 (70.8%) | 52 (65%) | 0.327 |
Dolichocolon, n (%) | 4 (1.6%) | 9 (11.3%) | < 0.001* |
Preoperative manometry, n (%) | 139 (55.6%) | 40 (50%) | 0.382 |
Resting pressure (median), mmHg | 81 (26–90) | 82 (78–87) | 0.000* |
Maximum squeeze pressure (median), mmHg | 78 (34–100) | 73 (47–92) | 0.158 |
Group I (LVMR) (n = 250) | Group II (PSR) (n = 80) | p value | |
---|---|---|---|
Operative time (min), mean ± SD | 90 ± 9 | 36 ± 9 | < 0.001* |
Blood loss (ml), median (range) | 99 (29–392) | 100 (29–292) | 0.162 |
Intraoperative complications, n (%) | 3 (1.2) | 3 (3.8) | 0.156 |
Type of complications, n (%)** | |||
Bleeding | 3 (100%) | 2 (66.7%) | |
Mechanical staple dysfunction | 0 (0%) | 1 (33.3%) | NA |
Conversion, n (%) | 0 (0) | – | – |
Number of stapler cartridges used ± SD | 5 ± 1 | – |
Group I (LVMR) (n = 250) | Group II (PSR) (n = 80) | p value | |
---|---|---|---|
Hospital stay (days), median (range) | 2 (2–5) | 5 (2–12) | < 0.001* |
Postoperative complications, n (%) | 19 (7.6%) | 17 (21.3%) | < 0.001* |
Readmission within 30 days, n (%) | 8 (3.2%) | 8 (10%) | 0.014* |
Mortality, n (%) | 3 (1.2%) | 4 (5%) | 0.040* |
Type of postoperative complications, n (%)** | 19 patients (7.6%) | 17 patients (21.3%) | < 0.001* |
Adhesive intestinal obstruction | 1 (5.3%) | 0 (0%) | NA |
Deep venous thrombosis | 1 (5.3%) | 1 (5.9%) | |
Infection at the staple line | 0 (0%) | 5 (29.4%) | |
Intra-abdominal abscess | 1 (5.3%) | 0 (0%) | |
Mesh-related complication | 3 (15.8%) | 0 (0%) | |
Myocardial infarction | 1 (5.3%) | 0 (0%) | |
Pelvic hematoma | 1 (5.3%) | 0 (0%) | |
Port site hernia | 2 (10.5%) | 0 (0%) | |
Prolonged ileus | 1 (5.3%) | 0 (0%) | |
Pulmonary infection | 1 (5.3%) | 1 (5.9%) | |
Rectal stenosis with fecal impaction | 2 (10.5%) | 0 (0%) | |
Staple line dehiscence with abscess | 0 (0%) | 2 (11.8%) | |
Stapler line bleeding | 0 (0%) | 3 (17.6%) | |
Urinary fistula | 1 (5.3%) | 0 (0%) | |
Urinary retention | 0 (0%) | 5 (29.4%) | |
Urinary tract infection | 1 (5.3%) | 0 (0%) | |
Wound infection | 3 (15.8%) | 0 (0%) | |
Treatment of complications, n (%)** | |||
Conservative treatment | 10 (52.6%) | 13 (76.5%) | |
Endoscopic dilatation | 2 (10.5%) | 0 (0%) | |
Radiological intervention | 1 (5.3%) | 0 (0%) | |
Surgical re-intervention | 6 (31.6%) | 4 (23.5%) | NA |
Indication for re-intervention | |||
Port site hernia | 2 | 0 | |
Mesh related complications | 1 | 0 | |
Pelvic hematoma | 1 | 0 | |
Urinary fistula | 1 | 0 | |
Adhesive IO | 1 | 0 | |
Stapler line bleeding | 0 | 2 | |
Stapler line dehiscence with pararectal abscess | 0 | 2 | |
Clavien–Dindo classification, n (%)** | |||
I | 3 (15.8%) | 4 (23.5%) | |
II | 4 (21.1%) | 6 (35.3) | |
III-A | 5 (26.3%) | 5 (29.4%) | |
III-B | 4 (21.1%) | 0 (0%) | |
IV | 1 (5.3%) | 1 (5.9%) | |
V | 2 (10.5%) | 1 (5.9%) | NA |
Group I (LVMR) (n = 250) | Group II (PSR) (n = 80) | p value | |
---|---|---|---|
Recurrence of prolapse, n (%) | 5 (2%) | 16 (20%) | < 0.001* |
Length of recurrence (mm), mean ± SD | 69 ± 9 | 96 ± 14 | < 0.001* |
Surgery–recurrence interval (months), mean ± SD | 40 ± 10 | 13 ± 9 | < 0.001* |
Baseline Wexner score, median (range) | 15 (12–18) | 15 (12–17) | 0.010* |
Wexner incontinence score, median (range) | |||
At 3 months | 1 (0–6) | 2 (0–6) | 0.023* |
At 4 years | 1 (0–13) | 2 (0–14) | 0.030* |
Baseline Altomare score, median (range) | 22 (12–32) | 22 (12–30) | 0.270 |
Altomare score, median (range) | |||
At 3 months | 0 (0–8) | 1 (0–12) | 0.025* |
At 4 years | 0 (0–22) | 1 (0–24) | 0.047* |
Fecal incontinence improvement, n (%) | |||
Improved | 106 (95.5%) | 31 (83.8%) | |
Initial improvement then worsening | 5 (4.5%) | 6 (16.2%) | 0.019* |
Obstructive defecation improvement, n (%) | |||
Improved | 48 (92.3%) | 14 (82.4%) | |
Initial improvement then worsening | 4 (7.7%) | 3 (17.6%) | 0.238 |
Development of new (de novo) symptoms, n (%) | |||
New constipation | 3 (1.2%) | 7 (9%) | |
Urge to defecate | 0 | 6 (7.5%) | < 0.001* |
Postoperative manometry, n (%) | 144 (57.6%) | 52 (65%) | 0.21 |
Resting pressure, mmHg | 82 (46–101) | 79 (34–87) | 0.004* |
Maximum squeeze pressure, mmHg | 113 (100–200) | 108 (85–130) | 0.000* |
Patient satisfaction, n (%) | |||
Satisfied | 242 (98%) | 62 (81.6%) | |
Not satisfied | 5 (2%) | 14 (18.4%) | < 0.001* |
Univariate | Multivariate | |||
---|---|---|---|---|
OR (95% CI) | p value | OR (95% CI) | p value | |
Age (years) | 0.963 (0.89–1.043) | 0.355 | – | – |
Sex (ref: male gender) | 1.132 (0.368–3.48) | 0.828 | – | – |
Parity (ref: nulliparous) | 1.274 (0.16–10.165) | 0.819 | – | – |
BMI | 0.994 (0.918–1.076) | 0.883 | – | – |
Duration of symptoms (months) | 1.097 (1.051–1.145) | < 0.001* | 1.11 (1.012–1.217) | 0.027* |
Length of prolapse (cm) | 1.502 (1.334–1.692) | < 0.001* | 1.407 (1.197–1.655) | < 0.001* |
Diabetes mellitus | 3.006 (0.988–9.142) | 0.053 | – | – |
Coronary diseases | 4.479 (1.023–19.605) | 0.047* | – | – |
Initial symptoms | – | – | ||
Prolapse with incontinence | 4.135 (1.167–14.653) | 0.028* | – | – |
Prolapse with OD | 1.667 (0.327–8.499) | 0.539 | – | – |
Preoperative manometry | 0.613 (0.251–1.498) | 0.283 | – | – |
Operative time (min) | 0.978 (0.962–0.993) | 0.005* | – | – |
Blood loss (ml) | 1.012 (1.007–1.018) | < 0.001* | – | – |
Group I | 0.082 (0.029–0.231) | < 0.001* | 0.118 (0.019–0.714) | 0.02* |
Baseline Wexner score | 0.841 (0.547–1.294) | 0.432 | – | – |
Baseline Altomare score | 1.001 (0.825–1.215) | 0.993 | – | – |